Ikena Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ikena Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Ikena Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.16M, a 48% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.16M -$3.83M -48% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.78M +$204K +4.46% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.24M +$323K +6.57% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $5.69M +$431K +8.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $7.99M +$2.41M +43.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.58M -$1.34M -22.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.92M -$1.31M -21% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $5.26M -$1.28M -19.6% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $5.59M -$1.26M -18.4% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $5.91M -$1.23M -17.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.23M -$1.21M -16.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $6.54M +$6.37M +3746% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $6.84M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $7.14M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $7.44M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $170K Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.